Vivosang Inc
Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.
Industries
N/A
Nr. of Employees
small (1-50)
Vivosang Inc
Products
Investigational pegylated hemoglobin-based oxygen carrier
A cell-free human hemoglobin therapeutic, chemically conjugated with polyethylene glycol to provide targeted oxygen delivery to capillaries, designed for rapid oxygenation of ischemic tissues and to be stored at ambient temperature for use in hemorrhagic resuscitation.
Investigational pegylated hemoglobin-based oxygen carrier
A cell-free human hemoglobin therapeutic, chemically conjugated with polyethylene glycol to provide targeted oxygen delivery to capillaries, designed for rapid oxygenation of ischemic tissues and to be stored at ambient temperature for use in hemorrhagic resuscitation.
Expertise Areas
- Hemoglobin-based oxygen therapeutics
- Protein PEGylation and conjugation chemistry
- Preclinical hemorrhage and ischemia models
- Formulation development for ambient-stable biologics
Key Technologies
- Protein PEGylation
- Hemoglobin purification from donor red blood cells
- In vivo hemorrhagic and exchange-transfusion models
- Oxygen-binding and kinetics assays
Key People
William Schindler JD
President, CEO
Kim Vandegriff PhD
Chief Science Officer
Ashok Malavalli MS
Chief of Operations
William Schindler JD
President, CEO
Kim Vandegriff PhD
Chief Science Officer
Ashok Malavalli MS
Chief of Operations
News & Updates
2023 Military Health Systems Research Symposium
Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'
2023 Military Health Systems Research Symposium
Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'